Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03453164
What this trial is testing

Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT)

Who this might be right for
Gastric Cancer
Fukushima Medical University 41
Early research (Phase 1)Study completedNCT04153565
What this trial is testing

Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)

Who this might be right for
Mesothelioma
Merck Sharp & Dohme LLC 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03480334
What this trial is testing

Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy

Who this might be right for
Classical Hodgkin Lymphoma
University of Cologne 26
Large-scale testing (Phase 3)Study completedNCT03040999
What this trial is testing

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

Who this might be right for
Head and Neck Neoplasms
Merck Sharp & Dohme LLC 804
Large-scale testing (Phase 3)Study completedNCT02564263
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 628
Not applicableNot Yet RecruitingNCT07376512
What this trial is testing

Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis

Who this might be right for
Non-Small Cell Lung CancerMelanoma (Skin Cancer)
Centre Georges Francois Leclerc 378
Testing effectiveness (Phase 2)UnknownNCT04544644
What this trial is testing

Combination Therapy in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06190067
What this trial is testing

Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma

Who this might be right for
Relapsed Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
Navy General Hospital, Beijing 40
Early research (Phase 1)Looking for participantsNCT07054307
What this trial is testing

MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma

Who this might be right for
Penile Cancer
Jiyan Liu 10
Testing effectiveness (Phase 2)Study completedNCT03171064
What this trial is testing

Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment

Who this might be right for
PD-1 AntibodiesExerciseMelanoma
University Hospital Heidelberg 39
Testing effectiveness (Phase 2)Study completedNCT01860638
What this trial is testing

A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma

Who this might be right for
Glioblastoma
Hoffmann-La Roche 296
Testing effectiveness (Phase 2)Active Not RecruitingNCT04214249
What this trial is testing

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT03713593
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 794
Testing effectiveness (Phase 2)UnknownNCT04268537
What this trial is testing

Immunoregulatory Therapy for 2019-nCoV

Who this might be right for
2019 nCoV, PD-1
Southeast University, China 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Testing effectiveness (Phase 2)Active Not RecruitingNCT05013450
What this trial is testing

Dupilumab_Metastatic NSCLC

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Thomas Marron 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996523
What this trial is testing

Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (SCC)
National Cancer Institute (NCI) 26
Not applicableLooking for participantsNCT06307080
What this trial is testing

Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis

Who this might be right for
Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03743662
What this trial is testing

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)UnknownNCT05816746
What this trial is testing

Decitabine and Anti-PD-1 in R/R DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaRelapse/RecurrenceExtranodal Extension+1 more
Chinese PLA General Hospital 20
Next Page
49